Day: June 4, 2025

News

Enliven Therapeutics Inc (ELVN) Stock: A Year of Decreases and Increases

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Enliven Therapeutics Inc’s current trading price is -27.21% away from its 52-week high, while its distance from the 52-week low is 64.36%. The stock’s

News

10x Genomics Inc: A Year of Highs, Lows, and Market Resilience

The market performance of 10x Genomics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $24.76 on 09/03/24, with the lowest value for the same timeframe being $6.78, recorded on 04/07/25. 52-week price history of TXG Stock A

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.